Management and Team

Discover the whole team behind our project, our collaborators and other partners

Vaxxel Team

Denis Cavert

MSc. Biochemical Engineering INSA / MS ESSEC
Former head of Baxter Vaccines Europe
Business Unit Director at Baxter and Merck
Serono, with sales up to 250m€

CEO

Dr. Manuel Rosa-Calatrava

Ph.D., Research Director at INSERM, Deputy head of Virpath University lab, head of Virnext
125 publications / 25 patents
Founder of Signia Therapeutics and VirexpR

Scientific Advisor

Pr. Guy Boivin

Professor and principal researcher in virology at the University of Laval (Québec)
400 publications / 10 patents
First to describe pathogenesis of hMPV

Clinical Development

Dr. Caroline Chupin

PharmD and Bioprocess Engineer
Cell culture and process development
PhD Student

Process Development

Marjorie Ray

MSc Cellular and Molecular Biology
Expertise in optimisation of virus production
15 years experience un Biotech and CDMP

Biomanufacturing

First-in-class international Founding Team

Dr. Bernard Fritzel

Clinical Development

Physician
Former VP International Scientific & Clinical Affairs, Pfizer Vaccines
Former VP International Scientific & Medical Affairs, Chiron Vaccines
Former Director Clinical Research, Sanofi Pasteur
Member of the French Covid-19 Vaccine C’tee

Dr. Bernard Fanget

CMC

Engineer and Ph.D, VP Drug Development, NeoVacs
Former VP Product Dev. & Production, Abivax
Former VP Pharmaceutical Dev. Flamel
Former VP Product Dev. & Industrialisation, Sanofi Pasteur
Member of the French Covid-19 Vaccine C’tee